|
- FDA’s artificial intelligence is supposed to revolutionize . . .
Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents Agency leaders insist the AI is getting better, and use is not mandatory
- The FDA Is Using an AI to Speed Up Drug Approvals and . . .
Insiders at the Food and Drug Administration are ringing alarm bells over the agency's use of an AI to fast-track drug approvals
- FDA Launches Agency-Wide AI Tool to Optimize Performance for . . .
Elsa is a large language model–powered AI tool designed to assist with reading, writing, and summarizing It can summarize adverse events to support safety profile assessments, perform faster
- The FDAs new drug-approving AI chatbot is not helping
The Food and Drug Administration's new AI tool — touted by Secretary of Health and Human Services (HHS) Robert F Kennedy, Jr as a revolutionary solution for shortening drug approvals — is
- FDA’s Elsa AI Tool Raises Accuracy and Oversight Concerns
Despite ambitions to streamline regulatory review, FDA’s Elsa platform has been prone to hallucinations, prompting internal scrutiny and questions about AI reliability and governance
- FDAs New Drug Approval AI Is Generating Fake Studies: Report
But a new report from CNN confirms all our worst fears Elsa, the FDA’s AI tool, is spitting out fake studies
- FDA’s new AI tool “Elsa” faces accuracy concerns despite . . .
FDA's AI tool, Elsa, faces scrutiny for producing unreliable data, raising concerns about its rapid implementation and impact on regulatory accuracy
|
|
|